Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin

被引:480
作者
Péterfy, M
Phan, J
Xu, P
Reue, K [1 ]
机构
[1] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA
[2] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA
关键词
D O I
10.1038/83685
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Mice carrying mutations in the fatty liver dystrophy (fld) gene have features of human lipodystrophy(1), a genetically heterogeneous group of disorders characterized by loss of body fat, fatty liver hypertriglyceridemia and insulin resistance(2-4). Through positional cloning, we have isolated the gene responsible and characterized two independent mutant alleles, fld and fld(2J). The gene (Lpin1) encodes a novel nuclear protein which we have named lipin. Consistent with the observed reduction of adipose tissue mass in fld and fld(2J) mice, wild-type Lpin1 mRNA is expressed at high levels in adipose tissue and is induced during differentiation of 3T3-L1 pre-adipocytes. Our results indicate that lipin is required for normal adipose tissue development, and provide a candidate gene for human lipodystrophy. Lipin defines a novel family of nuclear proteins containing at least three members in mammalian species, and homologs in distantly related organisms from human to yeast.
引用
收藏
页码:121 / 124
页数:4
相关论文
共 26 条
  • [1] CELLULAR AND MOLECULAR ASPECTS OF ADIPOSE-TISSUE DEVELOPMENT
    AILHAUD, G
    GRIMALDI, P
    NEGREL, R
    [J]. ANNUAL REVIEW OF NUTRITION, 1992, 12 : 207 - 233
  • [2] Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy
    Cao, H
    Hegele, RA
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (01) : 109 - 112
  • [3] A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2
    Comuzzie, AG
    Hixson, JE
    Almasy, L
    Mitchell, BD
    Mahaney, MC
    Dyer, TD
    Stern, MP
    MacCluer, JW
    Blangero, J
    [J]. NATURE GENETICS, 1997, 15 (03) : 273 - 276
  • [4] A physical map of 30,000 human genes
    Deloukas, P
    Schuler, GD
    Gyapay, G
    Beasley, EM
    Soderlund, C
    Rodriguez-Tomé, P
    Hui, L
    Matise, TC
    McKusick, KB
    Beckmann, JS
    Bentolila, S
    Bihoreau, MT
    Birren, BB
    Browne, J
    Butler, A
    Castle, AB
    Chiannilkulchai, N
    Clee, C
    Day, PJR
    Dehejia, A
    Dibling, T
    Drouot, N
    Duprat, S
    Fizames, C
    Fox, S
    Gelling, S
    Green, L
    Harrison, P
    Hocking, R
    Holloway, E
    Hunt, S
    Keil, S
    Lijnzaad, P
    Louis-Dit-Sully, C
    Ma, J
    Mendis, A
    Miller, J
    Morissette, J
    Muselet, D
    Nusbaum, HC
    Peck, A
    Rozen, S
    Simon, D
    Slonim, DK
    Staples, R
    Stein, LD
    Stewart, EA
    Suchard, MA
    Thangarajah, T
    Vega-Czarny, N
    [J]. SCIENCE, 1998, 282 (5389) : 744 - 746
  • [5] DORFLER H, 1993, CLIN INVESTIGATOR, V71, P264
  • [6] A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10
    Hager, J
    Dina, C
    Francke, S
    Dubois, S
    Houari, M
    Vatin, V
    Vaillant, E
    Lorentz, N
    Basdevant, A
    Clement, K
    Guy-Grand, B
    Froguel, P
    [J]. NATURE GENETICS, 1998, 20 (03) : 304 - 308
  • [7] LMNA R482Q mutation in partial lipodystrophy associated with reduced plasma leptin concentration
    Hegele, RA
    Cao, HN
    Huff, MW
    Anderson, CM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) : 3089 - 3093
  • [8] Altered gene expression pattern in the fatty liver dystrophy mouse reveals impaired insulin-mediated cytoskeleton dynamics
    Klingenspor, M
    Xu, P
    Cohen, RD
    Welch, C
    Reue, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) : 23078 - 23084
  • [9] LANGNER CA, 1991, J BIOL CHEM, V266, P11955
  • [10] LANGNER CA, 1989, J BIOL CHEM, V264, P7994